DnB Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.12M | Sell |
|
|||||
|
2025
Q1 | $2.9M | Buy |
|
|||||
|
2024
Q4 | $4.08M | Buy |
|
|||||
|
2024
Q3 | $2.94M | Buy |
|
|||||
|
2024
Q2 | $2.6M | Buy |
|
|||||
|
2024
Q1 | $2.06M | Sell |
|
|||||
|
2023
Q4 | $1.55M | Hold |
|
|||||
|
2023
Q3 | $1.51M | Buy |
|
|||||
|
2023
Q2 | $1.09M | Hold |
|
|||||
|
2023
Q1 | $1.28M | Sell |
|
|||||
|
2022
Q4 | $1.34M | Sell |
|
|||||
|
2022
Q3 | $1.26M | Buy |
|
|||||
|
2022
Q2 | $996K | Hold |
|
|||||
|
2022
Q1 | $1.24M | Sell |
|
|||||
|
2021
Q4 | $1.08M | Buy |
|
|||||
|
2021
Q3 | $1.24M | Buy |
|
|||||
|
2021
Q2 | $1.21M | Hold |
|
|||||
|
2021
Q1 | $1.41M | Buy |
|
|||||
|
2020
Q4 | $974K | Buy |
|
|||||
|
2020
Q3 | $726K | Buy |
|
|||||
|
2020
Q2 | $931K | Hold |
|
|||||
|
2020
Q1 | $678K | Sell |
|
|||||
|
2019
Q4 | $958K | Buy |
|
|||||
|
2019
Q3 | $587K | Hold |
|
|||||
|
2019
Q2 | $787K | Buy |
|
|||||
|
2019
Q1 | $1.21M | Sell |
|
|||||
|
2018
Q4 | $1.27M | Buy |
|
|||||
|
2018
Q3 | $1.7M | Buy |
|
|||||
|
2018
Q2 | $1.89M | Buy |
|
|||||
|
2018
Q1 | $1.17M | Buy |
|
|||||
|
2017
Q4 | $1.15M | Hold |
|
|||||
|
2017
Q3 | $1.07M | Buy |
|
|||||
|
2017
Q2 | $1.86M | Sell |
|
|||||
|
2017
Q1 | $2.36M | Buy |
|
|||||
|
2016
Q4 | $605K | Sell |
|
|||||
|
2016
Q3 | $4.73M | Hold |
|
|||||
|
2016
Q2 | $5.16M | Hold |
|
|||||
|
2016
Q1 | $5.5M | Buy |
|
|||||
|
2015
Q4 | $3.15M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $5.24M | Buy |
|
|||||
|
2014
Q4 | $2.76M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $452K | Sell |
|
|||||
|
2013
Q2 | $626K | Buy |
|